Evidence map›Paper›PMID 25522265›Full record

Trial reportMolecular nutrition & food research2015

Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract.

Lauren L Atwell, Anna Hsu, Carmen P Wong, Jan F Stevens, Deborah Bella, Tian-Wei Yu, Clifford B Pereira, Christiane V Löhr, John Mark Christensen, Roderick H Dashwood and 3 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Molecular nutrition & food research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 2 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Lauren L AtwellSchool of Biological and Population Health Sciences, Oregon State University, Corvallis, OR, USA.
Anna Hsu
Carmen P Wong
Jan F Stevens
Deborah Bella
Tian-Wei Yu
Clifford B Pereira
Christiane V Löhr
John Mark Christensen
Roderick H Dashwood
David E Williams
Jackilen Shannon
Emily Ho
Oregon State University · USOregon Health & Science University · USTexas A&M Health Science Center · US

Funding

Reducing Susceptibility to Environmental Stress Throughout the Life SpanP30ES000210 · NIEHS · OREGON STATE UNIVERSITY · PI BECKMAN, JOSEPH S · 1985 to 2015
$21.4M
Transplacental Chemoprevention of Lung Tumors and LymphomasP01CA090890 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DASHWOOD, RODERICK H · 2003 to 2014
$14.2M
Dietary histone deactylase inhibitors in prostate cancer preventionR01CA122906 · NCI · OREGON STATE UNIVERSITY · PI HO, EMILY · 2007 to 2011
$2.0M
NCI NIH HHS CA090890NCI NIH HHS CA122906NCI NIH HHS P01 CA090890NCI NIH HHS R01 CA122906NIEHS NIH HHS P30 ES000210
6 · The paper itself

Abstract

scopeSulforaphane (SFN), an isothiocyanate derived from crucifers, has numerous health benefits. SFN bioavailability from dietary sources is a critical determinant of its efficacy in humans. A key factor in SFN absorption is the release of SFN from its glucosinolate precursor, glucoraphanin, by myrosinase. Dietary supplements are used in clinical trials to deliver consistent SFN doses, but myrosinase is often inactivated in available supplements. We evaluated SFN absorption from a myrosinase-treated broccoli sprout extract (BSE) and are the first to report effects of twice daily, oral dosing on SFN exposure in healthy adults. METHODS AND

resultsSubjects consumed fresh broccoli sprouts or the BSE, each providing 200 μmol SFN daily, as a single dose and as two 100-μmol doses taken 12 h apart. Using HPLC-MS/MS, we detected ∼3 x higher SFN metabolite levels in plasma and urine of sprout consumers, indicating enhanced SFN absorption from sprouts. Twelve-hour dosing retained higher plasma SFN metabolite levels at later time points than 24-hour dosing. No dose responses were observed for molecular targets of SFN (i.e. heme oxygenase-1, histone deacetylase activity, p21).

conclusionWe conclude that the dietary form and dosing schedule of SFN may impact SFN absorption and efficacy in human trials.

Indexed as

AdultAnticarcinogenic AgentsBrassicaDietary SupplementsGene Expression RegulationGlycoside HydrolasesHeme Oxygenase-1Histone DeacetylasesHumansIntestinal AbsorptionIsothiocyanatesMiddle AgedMolecular Targeted TherapyPlant ExtractsSulfoxidesYoung AdultAnticarcinogenic AgentsGlycoside HydrolasesHeme Oxygenase-1Histone DeacetylasesHMOX1 protein, humanIsothiocyanatesPlant ExtractssulforaphaneSulfoxidesthioglucosidaseAbsorptionBroccoli sproutChemopreventionExcretionSulforaphane

Identifiers

PMID25522265
PMCPMC4394840
OpenAlexW2000465599

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.